Achieving a definitive treatment for chronic lymphocytic leukemia

At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Michael Hallek, MD, from the University of Cologne, Cologne, Germany, discusses the rapidly changing treatment landscape of chronic lymphocytic leukemia, including the development of new venetoclax-based combinations with improved treatment efficacy.